With the strong prescription dermatology brands and the new colleagues from Bayer, LEO Pharma advances significantly towards our goal of helping 125 million patients by 2025.” “We will broaden ...

"Gilead and LEO Pharma link on programmes for inflammatory conditions" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has ...

BALLERUP, Denmark--(BUSINESS WIRE)--LEO Pharma delivered another year of strong progress in 2024, with both sales growth and adjusted EBITDA margin ahead of the initial outlook for the year ...

"Junshi partners LEO Pharma for toripalimab distribution in Europe" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has ...

The EMA has started a review of Leo Pharma’s interleukin-13 inhibitor ... with Sanofi suggesting it could become a $10 billion brand at its peak. The drug’s mechanism of action simultaneously ...